LianBio
NASDAQ:LIAN

Watchlist Manager
LianBio Logo
LianBio
NASDAQ:LIAN
Watchlist
Price: 0.29 USD -3.01%
Updated: May 17, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

262.9m
-6%
Assets
Growth Rates:
1 Year
-25%
3 Years
-
5 Years
-
7 Years
-
10 Years
-
60.6m
+6%
Liabilities
Growth Rates:
1 Year
-23%
3 Years
-
5 Years
-
7 Years
-
10 Years
-
202.3m
-9%
Equity
Growth Rates:
1 Year
-26%
3 Years
-
5 Years
-
7 Years
-
10 Years
-

Balance Sheet Decomposition
LianBio

262.9m
Assets
60.6m
Liabilities
262.9m
Assets
60.6m
Liabilities
Current Assets 257.8m
Cash & Short-Term Investments 252.3m
Receivables 1.8m
Other Current Assets 3.7m
Non-Current Assets 5.1m
PP&E 5m
Other Non-Current Assets 100k
Current Liabilities 25.6m
Accounts Payable 6.2m
Accrued Liabilities 17.8m
Other Current Liabilities 1.6m
Non-Current Liabilities 35m
Other Non-Current Liabilities 35m

Balance Sheet
LianBio

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2019 Dec-2020 Dec-2021 Dec-2022
Assets
Cash & Cash Equivalents
43
254
228
79
Cash Equivalents
43
254
228
79
Short-Term Investments
0
0
155
223
Total Receivables
0
21
7
4
Other Current Assets
0
1
9
6
Total Current Assets
43
277
400
313
PP&E Net
1
3
7
7
PP&E Gross
1
3
7
7
Accumulated Depreciation
0
0
1
2
Other Long-Term Assets
0
0
20
0
Total Assets
44
N/A
279
+536%
426
+53%
320
-25%
Liabilities
Accounts Payable
0
4
3
2
Accrued Liabilities
1
2
11
22
Short-Term Debt
0
0
0
0
Other Current Liabilities
3
0
1
1
Total Current Liabilities
3
6
15
24
Long-Term Debt
0
0
0
0
Minority Interest
1
35
34
34
Other Liabilities
0
21
24
3
Total Liabilities
5
N/A
62
+1 226%
73
+17%
60
-17%
Equity
Common Stock
55
350
0
0
Retained Earnings
24
164
360
471
Additional Paid In Capital
9
31
713
733
Other Equity
0
0
1
2
Total Equity
39
N/A
217
+453%
354
+63%
260
-26%
Total Liabilities & Equity
44
N/A
279
+536%
426
+53%
320
-25%
Shares Outstanding
Common Shares Outstanding
105
105
107
107

See Also

Summary
LIAN intrinsic value, competitors valuation, and company profile.
DCF Valuation
LIAN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
LIAN stock valuation using valuation multiples.
Wall Street Estimates
LIAN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
LIAN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.